Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-19 4:15 pm Purchase | 2024-08-08 | 13G | Tenax Therapeutics, Inc. TENX | Venrock Healthcare Capital Partners III L.P. | 355,224 9.990% | 355,224 (New Position) | Filing |